Friday, March 29, 2013

ICH Stability Q1A - Q11



  • Stability Q1A - Q1F













    • Q1A(R2)Stability Testing of New Drug Substances and ProductsQ1A
    • Q1BStability Testing : Photostability Testing of New Drug Substances and Products
    • Q1CStability Testing for New Dosage Forms
    • Q1DBracketing and Matrixing Designs for Stability Testing of New Drug Substances and Products
    • Q1EEvaluation of Stability Data
    • Q1FStability Data Package for Registration Applications in Climatic Zones III and IV

     
    Analytical Validation Q2



    Q2(R1)Validation of Analytical Procedures: Text and MethodologyQ2A, Q2B
    Finalised Guidelines:
    October 1994/November 1996
    Description: The tripartite harmonised ICH Guideline on Text (previously coded Q2

    Impurities Q3A - Q3D



      • Q3A(R2)Impurities in New Drug Substances
      • Q3B(R2)Impurities in New Drug Products
      • Q3C(R5)Impurities: Guideline for Residual SolventsQ3C, Q3C(M)
      • Q3DImpurities: Guideline for Metal Impurities

    Pharmacopoeias Q4 - Q4B



      • Q4Pharmacopoeias
      • Q4APharmacopoeial Harmonisation
      • Q4BEvaluation and Recommendation of Pharmacopoeial Texts for Use in the ICH Regions
      • Q4B Annex 1R1Residue on Ignition/Sulphated Ash General Chapter
      • Q4B Annex 2R1Test for Extractable Volume of Parenteral Preparations General Chapter
      • Q4B Annex 3R1Test for Particulate Contamination: Sub-Visible Particles General Chapter
      • Q4B Annex 4AR1Microbiological Examination of Non-Sterile Products: Microbial Enumeration Tests General Chapter
      • Q4B Annex 4BR1Microbiological Examination of Non-Sterile Products: Tests for Specified Micro-Organisms General Chapter
      • Q4B Annex 4CR1Microbiological Examination of Non-Sterile Products: Acceptance Criteria for Pharmaceutical Preparations and Substances for Pharmaceutical Use General Chapter
      • Q4B Annex 5R1Disintegration Test General Chapter
      • Q4B Annex 6R1Uniformity of Dosage Units General Chapter
      • Q4B Annex 7R2Dissolution Test General Chapter
      • Q4B Annex 8R1Sterility Test General Chapter
      • Q4B Annex 9R1Tablet Friability General Chapter
      • Q4B Annex 10R1Polyacrylamide Gel Electrophoresis General Chapter
      • Q4B Annex 11Capillary Electrophoresis General Chapter
      • Q4B Annex 12Analytical Sieving General Chapter
      • Q4B Annex 13Bulk Density and Tapped Density of Powders General Chapter
      • Q4B Annex 14Bacterial Endotoxins Test General Chapter
      • Q4B FAQsFrequently Asked Questions

    Quality of Biotechnological Products Q5A - Q5E



      • Q5A(R1)Viral Safety Evaluation of Biotechnology Products Derived from Cell Lines of Human or Animal OriginQ5A
      • Q5BAnalysis of the Expression Construct in Cells Used for Production of r-DNA Derived Protein Products
      • Q5CStability Testing of Biotechnological/Biological Products
      • Q5DDerivation and Characterisation of Cell Substrates Used for Production of Biotechnological/Biological Products
      • Q5EComparability of Biotechnological/Biological Products Subject to Changes in their Manufacturing Process
     Specifications Q6A- Q6B



      • Q6ASpecifications : Test Procedures and Acceptance Criteria for New Drug Substances and New Drug Products: Chemical Substances
      • Q6BSpecifications : Test Procedures and Acceptance Criteria for Biotechnological/Biological Products

    Good Manufacturing Practice Q7



      • Q7Good Manufacturing Practice Guide for Active Pharmaceutical IngredientsQ7A
      • Q7 Q&AsQuestions and Answers: Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients

    Pharmaceutical Development Q8



      • Q8(R2)Pharmaceutical Development
      • Q8/9/10 Q&AsR4Q8/Q9/Q10 - Implementation
    Quality Risk Management Q9



      • Q9Quality Risk Management
      • Q8/9/10 Q&AsR4Q8/Q9/Q10 - Implementation
     

    Pharmaceutical Quality System Q10



      • Q10Pharmaceutical Quality System
      • Q8/9/10 Q&AsR4Q8/Q9/Q10 - Implementation

    Development and Manufacture of Drug Substances Q11



    Q11Development and Manufacture of Drug Substances (Chemical Entities and Biotechnological/Biological Entities)
    Finalised Guideline:
    May 2012




    For download all files click here Zip with all ICH Quality Guidelines in word format

0 comments:

Post a Comment

 
Design by Free WordPress Themes | Bloggerized by Lasantha - Premium Blogger Themes | cheap international calls